دورية أكاديمية
أعرض في EDS

Indocyanine green modified silica shells for colon tumor marking.

التفاصيل البيبلوغرافية
العنوان: Indocyanine green modified silica shells for colon tumor marking.
المؤلفون: Badaracco AG; Department of Nanoengineering, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States., Ward E; Department of Surgery, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States., Barback C; Department of Radiology, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States., Yang J; Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States., Wang J; Department of Nanoengineering, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States., Huang CH; Department of Nanoengineering, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States., Kim M; Department of Materials Science and Engineering, The University of Texas at Dallas, 800 West Campbell Road, Richardson, Texas 75080, USA., Wang Q; Department of Materials Science and Engineering, The University of Texas at Dallas, 800 West Campbell Road, Richardson, Texas 75080, USA., Nam S; Department of Materials Science and Engineering, The University of Texas at Dallas, 800 West Campbell Road, Richardson, Texas 75080, USA., Delong J; Department of Surgery, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States., Blair S; Department of Surgery, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States., Trogler WC; Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States., Kummel A; Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States.
المصدر: Applied surface science [Appl Surf Sci] 2020 Jan 01; Vol. 499. Date of Electronic Publication: 2019 Sep 05.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: New York] Country of Publication: Netherlands NLM ID: 101307063 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0169-4332 (Print) Linking ISSN: 01694332 NLM ISO Abbreviation: Appl Surf Sci Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: [Amsterdam : New York] : North-Holland, c1985-
مستخلص: Marking colon tumors for surgery is normally done with the use of India ink. However, non-fluorescent dyes such as India ink cannot be imaged below the tissue surface and there is evidence for physiological complications such as abscess, intestinal perforation and inconsistency of dye injection. A novel infrared marker was developed using FDA approved indocyanine green (ICG) dye and ultrathin hollow silica nanoshells (ICG/HSS). Using a positively charged amine linker, ICG was non-covalently adsorbed onto the nanoparticle surface. For ultra-thin wall 100 nm diameter silica shells, a bimodal ICG layer of < 3 nm is was formed. Conversely, for thicker walls on 2 μm diameter silica shells, the ICG layer was only bound to the outer surface and was 6 nm thick. In vitro testing of fluorescent emission showed the particles with the thinner coating were considerably more efficient, which is consistent with self-quenching reducing emission shown in the thicker ICG coatings. Ex-vivo testing showed that ICG bound to the 100 nm hollow silica shells was visible even under 1.5 cm of tissue. In vivo experiments showed that there was no diffusion of the ICG/nanoparticle marker in tissue and it remained imageable for as long as 12 days.
Competing Interests: 6. Disclosure of Conflicts of Interest Sarah Blair’s spouse is a co-founder, CEO and has equity interest in Viewpoint Medical. The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies. Andrew Kummel and William Trogler are stock holders, scientific advisory board members and scientific co-founders of Viewpoint Medical. The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies.
References: Int J Biomed Imaging. 2012;2012:940585. (PMID: 22577366)
Surg Today. 2009;39(3):214-8. (PMID: 19280280)
J Appl Physiol. 1976 Apr;40(4):575-83. (PMID: 776922)
ACS Nano. 2012 Jun 26;6(6):4694-701. (PMID: 22607191)
Photochem Photobiol. 2013 Nov-Dec;89(6):1273-82. (PMID: 23735010)
Small. 2010 Aug 16;6(16):1794-805. (PMID: 20623530)
Chem Commun (Camb). 2012 Sep 7;48(69):8628-30. (PMID: 22745939)
Nanoscale. 2014 Nov 6;6(23):14270-9. (PMID: 25321626)
J Biomed Opt. 2008 Jan-Feb;13(1):014025. (PMID: 18315383)
Surv Ophthalmol. 2000 Jul-Aug;45(1):15-27. (PMID: 10946079)
Adv Ther. 2012 Oct;29(10):864-73. (PMID: 23054693)
Gastrointest Endosc. 1991 Jan-Feb;37(1):65-8. (PMID: 1706285)
Adv Funct Mater. 2015 Jul 8;25(26):4049-4057. (PMID: 26955300)
Phys Med Biol. 1978 Jan;23(1):159-63. (PMID: 635011)
Colorectal Dis. 2009 Jun;11(5):527-30. (PMID: 19175629)
Biomaterials. 2012 Jul;33(20):5124-9. (PMID: 22498299)
J Am Chem Soc. 2010 Feb 17;132(6):1929-38. (PMID: 20092330)
ACS Appl Mater Interfaces. 2017 Jan 18;9(2):1719-1727. (PMID: 28001041)
Surg Endosc. 2019 Apr;33(4):1174-1179. (PMID: 30120582)
Tex Heart Inst J. 1987 Jun;14(2):133-8. (PMID: 15229732)
ACS Nano. 2008 Oct 28;2(10):2075-84. (PMID: 19206454)
Cancer Lett. 1996 Jan 2;98(2):169-73. (PMID: 8556705)
ACS Biomater Sci Eng. 2017 Aug 14;3(8):1780-1787. (PMID: 33429658)
Korean J Gastroenterol. 2014 Jul;64(1):45-8. (PMID: 25073671)
Nanoscale. 2017 Jan 7;9(1):99-103. (PMID: 27934996)
ACS Nano. 2013 Jul 23;7(7):6367-77. (PMID: 23802554)
Dis Colon Rectum. 2016 Feb;59(2):e14-8. (PMID: 26734978)
J Vac Sci Technol B Nanotechnol Microelectron. 2012 Mar;30(2):2C104. (PMID: 23616935)
Acc Chem Res. 2019 Jan 15;52(1):110-118. (PMID: 30484627)
J Biomed Opt. 2003 Jul;8(3):472-8. (PMID: 12880353)
Int J Nanomedicine. 2012;7:631-9. (PMID: 22334785)
Surf Sci Rep. 2014 Sep;69(2-3):132-158. (PMID: 25364083)
Biomaterials. 2015 Jan;37:415-24. (PMID: 25453969)
Dis Colon Rectum. 2015 Feb;58(2):264-7. (PMID: 25585088)
Chir Ital. 2003 Sep-Oct;55(5):657-61. (PMID: 14587109)
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009 Jul-Aug;1(4):360-8. (PMID: 20049803)
J Pharm Sci. 2003 Oct;92(10):2090-7. (PMID: 14502548)
Swiss Surg. 2003;9(6):307-10. (PMID: 14725100)
Talanta. 2012 Sep 15;99:387-93. (PMID: 22967569)
Sci Rep. 2017 Nov 16;7(1):15753. (PMID: 29147000)
Br J Cancer. 1998 Mar;77(6):1021-4. (PMID: 9528851)
J Clin Gastroenterol. 2000 Oct;31(3):233-6. (PMID: 11034004)
Nanotechnology. 2017 May 5;28(18):185102. (PMID: 28393763)
Nanomedicine. 2017 Apr;13(3):933-942. (PMID: 27840314)
Surg Endosc. 2009 Feb;23(2):347-51. (PMID: 18443867)
معلومات مُعتمدة: P30 CA023100 United States CA NCI NIH HHS; R33 CA177449 United States CA NCI NIH HHS; T32 CA153915 United States CA NCI NIH HHS
تواريخ الأحداث: Date Created: 20200901 Latest Revision: 20240607
رمز التحديث: 20240607
مُعرف محوري في PubMed: PMC7455021
DOI: 10.1016/j.apsusc.2019.143885
PMID: 32863496
قاعدة البيانات: MEDLINE
الوصف
تدمد:0169-4332
DOI:10.1016/j.apsusc.2019.143885